Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

830 nm LED light effectively treats and prevents skin redness and dark spots, while 590 nm LED light only helps prevent them.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Using a dexpanthenol ointment after micro-needling speeds up skin healing without affecting benefits.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

RTA 408 cream protects mice from radiation skin damage.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.